Identification of a 1-Mb common region at 16q24.1-24.2 deleted in hepatocellular carcinoma

Genes Chromosomes and Cancer

Volumn 28, Issue 1, 2000, Pages 38-44

  Bando, Koichi ^a   Nagai, Hisaki ^a   Matsumoto, Satoshi ^a   Koyama, Masaaki ^a   Kawamura, Naoki ^a   Tajiri, Takashi ^a   Onda, Masahiko ^a   Emi, Mitsuru ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 16Q; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE LOCATION; GENE LOCUS; GENE MAPPING; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; MARKER GENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

CARCINOMA, HEPATOCELLULAR; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 16; FEMALE; GENETIC MARKERS; HUMANS; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS;

EID: 0034106134     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(200005)28:1<38::AID-GCC5>3.0.CO;2-A     Document Type: Article

References (36)

1. Beasley RP, Hwang LY, Lin CC, Chien CS. 1981. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22707 men in Taiwan. Lancet 2:1129-1133.
2. Boige V, Laurent-Puig P, Fouchet P, Flejou J, Monges G, Bedossa P, Bioulac-Sage P, Capron F, Schmitz A, Olschwang S, Thomas G. 1997. Concerted nonsynthenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype. Cancer Res 57:1986-1990.
3. Buetow KH, Murray J, Israel J, London W, Smith M, Kew M, Blanquet V, Bréchot C, Redeker A, Govindarajah S. 1989. Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci USA 86:8852-8856.
4. Carter BS, Ewing CM, Ward W, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Isaacs WB. 1990. Allelic loss of chromosome 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 87:8751-8755.
5. Chou VH, Chung KC, Jeng LB, Chen TC, Liaw YF. 1998. Frequent allelic loss on chromosomes 4q and 16q associated with human hepatocellular carcinoma in Taiwan. Cancer Lett 123:1-6.
6. De Souza AT, Hankins GR, Washington MK, Orton TC, Jirtle RL. 1995. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet 11:447-149.
7. Dib C, Faure S, Fizames C, Samson O, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach J. 1996. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380:152-154.
8. Edmondson H, Steiner P. 1954. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7:462-503.
9. Emi M, Fujiwara Y, Nakajima T, Tsuchiya E, Tsuda H, Hirohashi S, Maeda Y, Tsuruta K, Miyaki M, Nakamura Y. 1992. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res 52:5368-5372.
10. Fujimori M, Tokino T, Hino O, Kitagawa T, Imamura T, Okamoto E, Mitsunobu N, Ishikawa T, Nakagama H, Harada H, Yagura M, Matsubara K, Nakamura Y. 1991. Allelotype study of primary hepatocellular carcinoma. Cancer Res 51:89-93.
11. Fujimoto Y, Hampton LL, Wirth PJ, Wang NJ, Xie JP, Thorgeirsson SS. 1994. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res 54:281-285.
12. Hansen LL, Yilmaz M, Overgaard J, Andersen J, Kruse TA. 1998. Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer. Cancer Res 58:2166-2169.
13. Hermanek P, Sobin LH. 1987. TNM Classification of Malignant Tumors, 4th ed. Berlin: Springer.
14. Iida A, Isobe R, Yoshimoto M, Kasumi F, Emi M. 1997. Localization of a breast cancer tumor-suppressor gene to a 3-cM interval within chromosomal region 16q22. Br J Cancer 75:264-267.
15. Japanese Liver Cancer Society. 1992. The General Rules for Clinical and Pathological Study of Primary Liver Cancer, 3rd ed. Tokyo: Kanehara.
16. Knudson AG. 1993. Antioncogenes and human cancer. Proc Natl Acad Sci USA 90:10914-10921.
17. Kusano N, Shiraishi K, Kudo K, Oga A, Okita K, Sasaki K. 1999. Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas. Hepatology 29:1858-1862.
18. Nagai H, Pineau P, Tiollais P, Buendia MA, Dejean A. 1997. Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene 14:2927-2933.
19. Piao Z, Kim H, Jeon BK, Lee WJ, Park C. 1997. Relationship between loss of heterozygosity of tumor suppressor genes and histologic differentiation in hepatocellular carcinoma. Cancer 80:865-872.
20. Piao Z, Park C, Park JH, Kim H. 1998. Allelotype analysis of hepatocellular carcinoma. Int J Cancer 75:29-33.
21. Piao Z, Park C, Kim JJ, Kim H. 1999. Deletion mapping of chromosome 16q in hepatocellular carcinoma. Br J Cancer 80:850-854.
22. Radford DM, Fair KL, Phillips NJ, Ritter JH, Steinbrueck T, Holt MS, Donis-Keller H. 1995. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q. Cancer Research 55:3399-3405.
23. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y, Choo QL, Houghton M, Kuo G. 1990. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 87:6547-6549.
24. Sakamoto M, Hirohashi S, Tsuda H, Ino Y, Shimosato Y, Yamasaki S, Makuuchi M, Hasegawa H, Terada M, Hosoda Y. 1988. Increasing incidence of hepatocellular carcinoma possibly associated with non-A, non-B hepatitis in Japan, disclosed by hepatitis B virus DNA analysis ofsurgically resected cases. Cancer Res 48:7294-7297.
25. Sato M, Mori Y, Sakurada A, Fukushige S, Ishikawa Y, Tsuchiya E, Saito Y, Nukiwa T, Fujimura S, Horii A. 1998. Identification of a 910-Kb region of common allelic loss in chromosome hands 16q24.1-q24.2 in human lung cancer. Genes Chromosomes Cancer 22:1-8.
26. Shirahama S, Ogura K, Takami H, Ito K, Tohsen T, Miyauchi A, Nakamura Y. 1998. Mutational analysis of the RET proto-oncogene in 71 Japanese patients with medullary thyroid carcinoma. J Hum Genet 43:101-106.
27. Skirnisdottir S, Eiriksdottir G, Baldursson T, Barkardottir RB, Egilsson V, Ingvarsson S. 1995. High frequency of allelic imbalance at chromosome region 16q22-23 in human breast cancer: correlation with high PgR and S phase. Int J Cancer Pred Oncol 64:112-116.
28. Suzuki H, Komiya A, Emi M, Kuramochi H, Shiraishi T, Yatani R, Shimazaki J. 1996. Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers. Genes Chromosomes Cancer 17:225-233.
29. Takahashi K, Kudo J, Ishibashi H, Hirata Y, Niho Y. 1993. Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma. Hepatology 17:794-799.
30. Takeichi M. 1991. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251:1451-1455.
31. Tsuda H, Zhang W, Shimosato Y, Yokota J, Terada M, Sugimura T, Miyamura T, Hirohashi S. 1990. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA 87:6791-6794.
32. Tsuda H, Callen DF, Fukutomi T, Nakamura Y, Hirohashi S. 1994. Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread. Cancer Res 54:513-517.
33. Tsukamoto K, Haruta K, Shiba T, Emi M. 1998. Isolation and mapping of a polymorphic CA repeat sequence at human interleukin 6 locus. J Hum Genet 43:71-72.
34. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL. 1988. Genetic alterations during colorectal-tumor development. N Engl J Med 319:525-532.
35. Wang HP, Rogler CE. 1988. Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas. Cytogenet Cell Genet 48:72-78.
36. Yeh SH, Chen PJ, Chen HL, Wang CC, Chen DS. 1994. Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res 54:4188-4192.